Skip to content

Jeff Cislini, SVP & General Counsel at Revolution Medicines, sold RVMD on Sep 25, 2026

Data as of Oct 16

▼ SELL$159K765 shares at $207.32Jeff Cislini SVP & General CounselRVMD Revolution Medicines, Inc.
Watch RVMD
Traded
Sep 25, 2026
Disclosed
Sep 29, 2026
Filed
4 days after the trade

Form 4s are due within two business days.

Official filing (SEC Form 4) ↗

The price around the disclosure

Jeff Cislini, SVP & General Counsel at Revolution Medicines, sold RVMD on Sep 25, 2026TRADEDDISCLOSED
RVMDSimilar stocks (XLV — its sector index fund), rebased to RVMD's price on the disclosure day
RVMD since disclosure
−13.0%
after the sale
Similar stocks (XLV) since disclosure
+3.5%
XLV — its sector index fund

Change in closing price from Sep 29, 2026 (the first trading day on or after disclosure) to Oct 16, 2026. Dividends excluded. Not a return anyone earned.

Our take

None of our tested rules fired on this trade.

See every trade on RVMD →